Dr Tania Dexter, senior medical officer at Anthony Nolan, said: “It’s encouraging to see further evidence of the efficacy of blinatumomab for patients whose leukaemia has unfortunately returned.
“At Anthony Nolan, we see every day how challenging the treatment process can be for children with leukaemia, particularly if they require a stem cell transplant.
“While potentially lifesaving, recovery can take months and leave children with long-term side effects.
“We welcome research into kinder treatment regimes for children that also gives them the option to receive treatment in their home, where they’re often most comfortable.”
Contact details are available to account holders.
Create a free account to get in touch with this expert.